Chargement en cours...

Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron

PURPOSE: Nausea and vomiting are major adverse effects of chemotherapy and can greatly impact patients’ quality of life. Although chemotherapy-induced nausea and vomiting (CINV) prevalence is high, treatment remains difficult. Palonosetron is a 5-hydroxytryptamine receptor antagonist (5-HT(3)RA) app...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Clin Risk Manag
Auteurs principaux: Zhou, Michelle, Popovic, Marko, Pasetka, Mark, Pulenzas, Natalie, Ahrari, Soha, Chow, Edward, DeAngelis, Carlo
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4435088/
https://ncbi.nlm.nih.gov/pubmed/25999723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S68130
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!